N R Life Care

Pantoprazole Chloro Intermediate is a specialty organic chemical intermediate associated with the synthesis of Pantoprazole, a proton pump inhibitor (PPI) used in pharmaceutical formulations for acid-related gastrointestinal disorders.

Pantoprazole manufacturing involves multiple chemical synthesis stages, including the preparation of substituted pyridine and benzimidazole intermediates. Certain chlorinated pyridine derivatives serve as intermediates in these manufacturing processes.

Pantoprazole Chloro Intermediate is intended for further chemical processing and is not a finished Active Pharmaceutical Ingredient (API). Its exact chemical structure, identity, and application depend on the specific intermediate supplied.

Product Name: Pantoprazole Chloro Intermediate

Chemical Name: As per manufacturer specifications and verified chemical identity.

Common Name: Pantoprazole Chloro Intermediate / Pantoprazole Chemical Intermediate / Pantoprazole Synthesis Intermediate

CAS No.: To be confirmed from manufacturer COA.

Molecular Formula: As per verified chemical structure.

Molecular Weight: As per verified chemical structure.

Category: API Intermediate / Pharmaceutical Chemical Intermediate

Grade: Industrial / Intermediate Grade, subject to manufacturer specifications.

Appearance: As per manufacturer COA.

Source: Synthetically manufactured organic chemical intermediate.

Solubility: As per manufacturer specifications.

Chemical Classification: Organic Pharmaceutical Intermediate

Functional Category: Pantoprazole Synthesis Intermediate

Applications:

• Pantoprazole API manufacturing

• Pharmaceutical intermediate synthesis

• Multistep organic chemical synthesis

• Pharmaceutical process development

• Chemical research and development

• Analytical method development

• Intermediate quality-control testing

Key Features:

• Specialty pharmaceutical intermediate

• Associated with Pantoprazole synthesis

• Intended for further chemical conversion

• Suitable for specified industrial synthesis processes

• Batch-specific chemical quality parameters

• Defined chemical identity subject to verification

Packaging: Suitable sealed chemical containers, subject to availability.

Storage: Follow manufacturer instructions. Protect from moisture, excessive heat, light, and incompatible substances as applicable.

Supplier & Trader: NR LIFE CARE, Ahmedabad, Gujarat, India.

Product Quality: Specifications may include identification, assay or purity, related impurities, moisture, and residual solvents, depending on the intermediate.

Documentation: Certificate of Analysis (COA), technical specifications, and Safety Data Sheet (SDS), subject to availability.

Safety: Intended for authorized chemical and pharmaceutical manufacturing. Follow appropriate industrial handling procedures and manufacturer SDS instructions.

Regulatory Note: This material is a pharmaceutical intermediate, not Pantoprazole API or a finished medicinal product. Its suitability for pharmaceutical synthesis must be established through manufacturer documentation and appropriate quality assessment.

Ethambutol Hydrochloride is a synthetic antimycobacterial Active Pharmaceutical Ingredient (API) widely used in the manufacturing of pharmaceutical formulations for the treatment of tuberculosis (TB). It belongs to the first-line antitubercular drug category and is generally administered in combination with other appropriate antituberculosis medicines.

Ethambutol Hydrochloride acts by inhibiting mycobacterial arabinosyltransferase enzymes involved in the biosynthesis of arabinogalactan, an essential component of the mycobacterial cell wall. This interferes with cell wall formation and inhibits the growth of susceptible mycobacteria.

Ethambutol HCl is used in approved oral pharmaceutical formulations, including single-ingredient tablets and fixed-dose combination products containing other antitubercular agents.

Product Name: Ethambutol Hydrochloride API

Chemical Name: (2S,2'S)-2,2'-(Ethane-1,2-diyldiimino)dibutan-1-ol dihydrochloride

Common Name: Ethambutol HCl / Ethambutol Hydrochloride / Ethambutol API

CAS No.: 1070-11-7

Molecular Formula: C10H24N2O2·2HCl

Molecular Weight: 277.23 g/mol

Category: Active Pharmaceutical Ingredient / Antitubercular API / Antimycobacterial Agent

Grade: Pharmaceutical Grade / IP / BP / USP, subject to applicable pharmacopoeial standards and batch-specific verification.

Appearance: White or almost white crystalline powder.

Source: Synthetically manufactured pharmaceutical compound.

Solubility: Freely soluble in water; solubility in other solvents depends on conditions.

Chemical Classification: Synthetic Ethylenediamine Derivative

Therapeutic Category: Antitubercular / Antimycobacterial Agent

Mechanism of Action: Inhibits mycobacterial arabinosyltransferase enzymes, disrupting cell wall arabinogalactan biosynthesis.

Applications:

• Antituberculosis tablet manufacturing

• Approved oral antitubercular formulations

• Fixed-dose combination TB medicines

• Pharmaceutical formulation development

• Antimycobacterial API analytical testing

• Pharmaceutical quality-control studies

• Stability and compatibility studies

• Regulated pharmaceutical manufacturing

Key Features:

• Synthetic first-line antitubercular API

• Antimycobacterial pharmacological activity

• Water-soluble hydrochloride salt

• Used in approved combination TB treatment regimens

• Defined chemical structure

• Batch-specific pharmaceutical quality specifications

Packaging: Pharmaceutical-grade, tightly sealed, moisture-resistant containers, subject to availability.

Storage: Store according to manufacturer recommendations, protected from moisture, excessive heat, and direct light.

Supplier & Trader: NR LIFE CARE, Ahmedabad, Gujarat, India.

Product Quality: Specifications may include identification, assay, related substances, specific optical rotation, loss on drying, residual solvents, and applicable pharmacopoeial tests.

Documentation: Certificate of Analysis (COA), technical specifications, and Safety Data Sheet (SDS), subject to availability.

Safety: Intended for authorized pharmaceutical manufacturing. Ethambutol-containing medicines may cause optic neuropathy and require appropriate medical monitoring.

Regulatory Note: Pharmaceutical grade, approved indications, and manufacturing suitability must be verified against applicable regulatory standards and batch-specific manufacturer documentation.

Piracetam is a synthetic pharmaceutical Active Pharmaceutical Ingredient (API) belonging to the racetam class of compounds. It is a cyclic derivative of gamma-aminobutyric acid (GABA) and is used in certain countries for approved neurological pharmaceutical formulations.

Piracetam is believed to influence neuronal membrane properties and aspects of neurotransmission and cellular function. Its precise mechanism of action is not fully established, and it does not act as a conventional direct GABA receptor agonist.

Piracetam is used in selected neurological formulations, including treatment of cortical myoclonus in jurisdictions where this indication is approved. Other therapeutic applications depend on country-specific regulatory authorization.

Product Name: Piracetam API Powder

Chemical Name: 2-(2-Oxopyrrolidin-1-yl)acetamide

Common Name: Piracetam / Piracetam API / 2-Oxo-1-pyrrolidineacetamide

CAS No.: 7491-74-9

Molecular Formula: C6H10N2O2

Molecular Weight: 142.16 g/mol

Category: Active Pharmaceutical Ingredient / Neurological API / CNS API

Grade Standard: USP Grade, subject to verification of applicable monograph and batch documentation.

Appearance: White or almost white crystalline powder.

Source: Synthetically manufactured pharmaceutical compound.

Solubility: Freely soluble in water.

Chemical Classification: Racetam Derivative / Cyclic Lactam

Therapeutic Category: Neurological Agent

Mechanism of Action: Modulates neuronal membrane-associated processes; its precise therapeutic mechanism remains incompletely understood.

Applications:

• Approved neurological medicine manufacturing

• Piracetam tablet manufacturing

• Pharmaceutical capsule formulations

• Approved oral liquid preparations

• Pharmaceutical formulation development

• API analytical method development

• Stability and compatibility studies

• Regulated pharmaceutical manufacturing

Key Features:

• Synthetic racetam-class API

• Established chemical identity

• Water-soluble pharmaceutical compound

• Used in selected neurological formulations

• Suitable for oral dosage form development

• Batch-specific quality specifications

Packaging: Pharmaceutical-grade, tightly sealed, moisture-resistant containers, subject to availability.

Storage: Store according to manufacturer recommendations in a cool, dry environment, protected from moisture and excessive heat.

Supplier & Trader: NR LIFE CARE, Ahmedabad, Gujarat, India

Product Quality: Specifications may include identification, assay, related substances, loss on drying, residual solvents, and applicable pharmacopoeial tests.

Documentation: Certificate of Analysis (COA), technical specifications, and Safety Data Sheet (SDS), subject to availability.

Safety: Pharmaceutical API intended for authorized manufacturing and professional use.

Regulatory Note: USP Grade must be supported by an applicable official standard and batch-specific testing. Product approval and permitted therapeutic applications vary by country.

Carbocisteine is a synthetic mucoregulatory and mucolytic Active Pharmaceutical Ingredient (API) belonging to the amino acid derivative class. It is widely used in pharmaceutical manufacturing for approved oral formulations intended to manage respiratory conditions associated with excessive or abnormal mucus production.

Carbocisteine helps regulate mucus composition and improve mucus clearance by influencing the properties of respiratory secretions. It is used in selected respiratory formulations for productive cough and other mucus-related respiratory conditions, subject to local approvals.

It is commonly incorporated into oral syrups, capsules, and other approved pharmaceutical dosage forms.

Product Name: Carbocisteine IP BP USP Powder

Chemical Name: S-(Carboxymethyl)-L-cysteine

Common Name: Carbocisteine / Carbocysteine / S-Carboxymethyl-L-cysteine

CAS No.: 638-23-3

Molecular Formula: C5H9NO4S

Molecular Weight: 179.19 g/mol

Category: Active Pharmaceutical Ingredient / Respiratory API

Grade: IP / BP / USP / Pharmaceutical Grade, subject to batch-specific compliance.

Appearance: White to almost white crystalline powder.

Source: Synthetically manufactured amino acid derivative.

Solubility: Slightly soluble in water; solubility varies with pH.

Chemical Classification: Sulfur-Containing Amino Acid Derivative

Therapeutic Category: Mucolytic / Mucoregulator

Mechanism of Action: Helps normalize respiratory mucus properties and supports mucociliary clearance.

Applications:

• Mucolytic syrup manufacturing

• Respiratory capsule formulations

• Oral pharmaceutical preparations

• Productive cough medicine manufacturing

• Respiratory formulation development

• API analytical method development

• Quality control and stability testing

• Regulated pharmaceutical manufacturing

Key Features:

• Established mucoregulatory API

• Sulfur-containing amino acid derivative

• Used in approved respiratory formulations

• Supports mucus clearance

• Defined chemical structure

• Batch-specific quality specifications

Packaging: Pharmaceutical-grade, tightly sealed, moisture-resistant containers, subject to availability.

Storage: Store according to manufacturer recommendations in a cool, dry environment. Protect from moisture and contamination.

Supplier & Trader: NR LIFE CARE, Ahmedabad, Gujarat, India

Product Quality: Batch specifications may include identification, assay, related substances, specific optical rotation, water content, residual solvents, and applicable pharmacopoeial tests.

Documentation: Certificate of Analysis (COA), technical specifications, and Safety Data Sheet (SDS) may be available upon request.

Safety: Pharmaceutical API intended for authorized manufacturing and professional use.

Regulatory Note: IP, BP, and USP compliance must be verified through applicable pharmacopoeial testing and batch documentation.

Polyvinylpyrrolidone PVP K90 is a high-molecular-weight, water-soluble synthetic polymer widely used in pharmaceutical, cosmetic, personal care, and industrial formulations. Also known as Povidone K90, it is valued for its excellent binding, film-forming, thickening, and stabilizing properties.

PVP K90 is manufactured through the polymerization of N-vinyl-2-pyrrolidone. Its high molecular weight provides greater solution viscosity compared with lower K-value grades such as PVP K30.

In pharmaceutical manufacturing, PVP K90 is used as a binder and formulation excipient. It is also used in cosmetic and personal care products for film formation, viscosity modification, and formulation stability.

Product Name: Polyvinylpyrrolidone PVP K90

Chemical Name: Poly(1-vinyl-2-pyrrolidone)

Common Name: PVP K90 / Povidone K90 / Polyvinylpyrrolidone / Polyvidone K90

CAS No.: 9003-39-8

Molecular Formula: (C6H9NO)n

Molecular Weight: Variable; high-molecular-weight polymer.

Category: Pharmaceutical Excipient / Synthetic Polymer / Binder / Thickening Agent

Grade: Pharmaceutical / Cosmetic / Industrial Grade, subject to batch-specific compliance.

Appearance: White to off-white hygroscopic powder.

Source: Synthetically manufactured polymer.

Solubility: Soluble in water and selected polar organic solvents.

K-Value: K90 grade; actual viscosity characteristics depend on batch specifications.

Functions: Binder, film-forming agent, thickener, stabilizer, and viscosity modifier.

Applications:

• Pharmaceutical tablet manufacturing

• Wet granulation formulations

• Tablet binder applications

• Film-forming pharmaceutical formulations

• Cosmetic cream and lotion manufacturing

• Hair styling gels and sprays

• Personal care formulations

• Adhesive manufacturing

• Industrial coating formulations

• Polymer research and development

• Formulation stability improvement

• Analytical testing and quality control

Key Features:

• High-molecular-weight PVP polymer

• Excellent binding properties

• Water-soluble synthetic polymer

• Effective film-forming agent

• High solution viscosity

• Suitable for pharmaceutical and cosmetic formulations

• Available in application-specific grades

Packaging: Moisture-resistant packaging, including sealed HDPE bags, laminated bags, or lined fibre drums, subject to commercial availability.

Storage: Store in tightly closed containers in a cool, dry area. Protect from moisture, excessive heat, and contamination.

Supplier: NR LIFE CARE

Product Quality: Batch-specific specifications may include K-value, viscosity, pH, loss on drying, residual N-vinylpyrrolidone monomer, peroxide value, and heavy metal limits.

Documentation: Certificate of Analysis (COA), technical specifications, and Safety Data Sheet (SDS) may be available upon request.

Regulatory Note: Pharmaceutical applications require suitable excipient-grade material and compliance with applicable pharmacopoeial standards.

L-Methylfolate Calcium is a biologically active folate derivative used in nutraceutical, dietary supplement, and pharmaceutical manufacturing. It is the calcium salt of L-5-methyltetrahydrofolate (L-5-MTHF), an important form of vitamin B9 involved in one-carbon metabolism and normal cellular functions.

L-Methylfolate is a naturally occurring, metabolically active form of folate that participates in methylation reactions, amino acid metabolism, DNA synthesis, and red blood cell formation.

Unlike folic acid, L-Methylfolate does not require conversion by the MTHFR enzyme to become 5-methyltetrahydrofolate. It is commonly used in specialized folate supplements, prenatal nutrition products, and approved pharmaceutical formulations.

Product Name: L-Methylfolate Calcium Powder

Chemical Name: Calcium L-5-Methyltetrahydrofolate

Common Name: L-Methylfolate Calcium / Calcium L-5-MTHF / Levomefolate Calcium / Active Folate

CAS No.: 151533-22-1

Molecular Formula: C20H23CaN7O6

Molecular Weight: 497.52 g/mol

Category: Nutraceutical Ingredient / Vitamin B9 Derivative / Active Folate / Pharmaceutical Raw Material

Grade: Nutraceutical Grade / Food Grade / Pharmaceutical Grade, subject to batch-specific compliance.

Appearance: White to pale yellow or yellowish crystalline powder.

Source: Manufactured through controlled chemical or biotechnological processes.

Solubility: Slightly soluble in water; solubility depends on pH and formulation conditions.

Nutritional Category: Active Folate / Vitamin B9

Functions: Folate supplementation, one-carbon metabolism support, methylation pathway support, and nutritional formulation ingredient.

Applications:

• Active folate supplement manufacturing

• Prenatal nutritional formulations

• Vitamin B9 supplement production

• Multivitamin and mineral formulations

• Nutraceutical capsule manufacturing

• Dietary supplement tablets

• Specialized nutritional premixes

• Folate deficiency management formulations

• Pharmaceutical formulation development

• Nutritional research and development

• Analytical testing and quality control

Key Features:

• Biologically active form of folate

• Calcium salt of L-5-MTHF

• Does not require MTHFR-mediated activation

• Supports normal folate-dependent metabolism

• Used in specialized nutritional formulations

• Suitable for authorized nutraceutical manufacturing

Packaging: Suitable moisture-resistant and light-protective packaging, including sealed HDPE containers or lined drums, subject to commercial availability.

Storage: Store in tightly closed containers under manufacturer-recommended conditions. Protect from moisture, excessive heat, light, and oxidation.

Supplier: NR LIFE CARE

Product Quality: Batch-specific specifications may include identification, assay, stereochemical purity, related substances, water content, calcium content, residual solvents, and microbial limits.

Documentation: Certificate of Analysis (COA), technical specifications, and Safety Data Sheet (SDS) may be available upon request.

Regulatory Note: Intended for authorized nutraceutical and pharmaceutical manufacturing in accordance with applicable regulations.

Sucralfate is a gastrointestinal protective active pharmaceutical ingredient (API) widely used in pharmaceutical manufacturing for the production of medicines intended to treat and manage certain gastrointestinal ulcers.

Sucralfate is a basic aluminium salt of sucrose octasulfate. In an acidic environment, it forms a viscous, adhesive protective complex that binds to damaged gastrointestinal mucosal surfaces, creating a physical barrier against gastric acid, pepsin, and bile salts.

Its therapeutic action is primarily local, with minimal systemic absorption. Sucralfate is commonly used in approved oral tablet and suspension formulations for duodenal ulcer treatment and other authorized gastrointestinal applications.

Product Name: Sucralfate IP BP USP Powder

Chemical Name: Basic Aluminium Sucrose Sulfate Complex

Common Name: Sucralfate / Sucralfate API / Sucralfate Powder / Aluminium Sucrose Sulfate

CAS No.: 54182-58-0

Molecular Formula: Variable-composition aluminium sucrose sulfate complex.

Molecular Weight: Not represented by a single fixed molecular weight.

Category: Active Pharmaceutical Ingredient / Gastrointestinal Protective Agent / Antiulcer API

Grade: IP / BP / USP / Pharmaceutical Grade, subject to batch-specific pharmacopoeial compliance.

Appearance: White to off-white amorphous powder.

Source: Synthetically manufactured pharmaceutical compound.

Solubility: Practically insoluble in water and most common organic solvents.

Therapeutic Category: Gastrointestinal Mucosal Protectant / Antiulcer Agent

Mechanism of Action: Forms an adhesive protective barrier over damaged gastrointestinal mucosal surfaces.

Applications:

• Sucralfate tablet manufacturing

• Oral suspension formulations

• Duodenal ulcer treatment medicines

• Gastrointestinal protective formulations

• Antiulcer pharmaceutical manufacturing

• Generic gastrointestinal medicine production

• Oral dosage formulation development

• Pharmaceutical research and development

• Analytical testing and quality control

Key Features:

• Established gastrointestinal protective API

• Forms a protective barrier over ulcerated tissue

• Primarily local gastrointestinal action

• Minimal systemic absorption

• Used in approved oral formulations

• Suitable for authorized pharmaceutical manufacturing

Packaging: Pharmaceutical-grade moisture-resistant packaging, including sealed HDPE containers or lined drums, subject to availability.

Storage: Store in tightly closed containers under manufacturer-recommended conditions. Protect from moisture, excessive heat, and contamination.

Supplier: NR LIFE CARE

Product Quality: Batch-specific specifications may include identification, aluminium content, sulfate content, acid-neutralizing capacity, loss on drying, related impurities, and applicable pharmacopoeial parameters.

Documentation: Certificate of Analysis (COA), technical specifications, and Safety Data Sheet (SDS) may be available upon request.

Regulatory Note: Intended for authorized pharmaceutical manufacturing in accordance with applicable regulations.

Neomycin Sulphate is a broad-spectrum aminoglycoside antibiotic active pharmaceutical ingredient (API) used in pharmaceutical and veterinary medicine manufacturing. It is obtained through the fermentation of selected Streptomyces species and is primarily used in formulations intended to treat infections caused by susceptible bacteria.

Neomycin Sulphate works by binding to the bacterial 30S ribosomal subunit, interfering with protein synthesis and causing errors in the translation of genetic information. This mechanism contributes to its bactericidal activity against susceptible microorganisms.

Neomycin Sulphate is commonly used in approved topical, ophthalmic, otic, and selected oral pharmaceutical formulations. Its use is subject to appropriate regulatory approvals and safety requirements.

Product Name: Neomycin Sulphate API Powder

Chemical Name: Neomycin Sulfate

Common Name: Neomycin Sulphate / Neomycin Sulfate / Neomycin API / Neomycin Sulphate Powder

CAS No.: 1405-10-3

Molecular Formula: Variable; neomycin sulphate is a mixture of related aminoglycoside sulphate salts.

Molecular Weight: Varies according to component composition and sulphate content.

Category: Active Pharmaceutical Ingredient / Aminoglycoside Antibiotic / Antibacterial API / Veterinary Pharmaceutical Raw Material

Grade: IP / BP / USP / Pharmaceutical Grade / Veterinary Grade, subject to batch-specific compliance.

Appearance: White to yellowish-white powder.

Source: Fermentation-derived antibiotic produced using selected Streptomyces species, followed by purification and sulphate salt formation.

Solubility: Freely soluble in water; practically insoluble in most common organic solvents.

Functions: Aminoglycoside antibiotic, bacterial protein synthesis inhibitor, and antibacterial pharmaceutical ingredient.

Applications:

• Topical antibiotic cream manufacturing

• Antibacterial ointment formulations

• Ophthalmic antibiotic preparations

• Otic pharmaceutical formulations

• Approved oral antibiotic preparations

• Dermatological pharmaceutical manufacturing

• Combination antibiotic formulations

• Veterinary pharmaceutical manufacturing

• Generic antibacterial medicine production

• Pharmaceutical formulation development

• Antimicrobial research and development

• Analytical testing and quality control

Key Features:

• Established aminoglycoside antibiotic API

• Bactericidal activity against susceptible bacteria

• Inhibits bacterial protein synthesis

• Freely soluble in water

• Used in approved topical and other formulations

• Suitable for authorized pharmaceutical manufacturing

Packaging: Available in suitable pharmaceutical-grade, moisture-resistant packaging, including sealed HDPE containers, laminated bags, or lined fibre drums, subject to commercial availability.

Storage: Store in tightly closed containers under manufacturer-recommended conditions. Protect from moisture, excessive heat, and contamination.

Supplier: NR LIFE CARE

Product Quality: Batch-specific specifications may include identification, microbiological potency, related substances, neomycin component profile, sulphate content, water content, and applicable pharmacopoeial parameters.

Documentation: Certificate of Analysis (COA), technical specifications, and Safety Data Sheet (SDS) may be provided subject to supplier availability.

Chloroquine Phosphate Powder is an active pharmaceutical ingredient belonging to the 4-aminoquinoline class of antimalarial medicines. It is widely recognized for its antiprotozoal properties and is used in pharmaceutical formulations for the treatment and prevention of malaria caused by chloroquine-sensitive Plasmodium species. Chloroquine Phosphate interferes with heme detoxification within malaria parasites, resulting in antimalarial activity. It is also used in certain approved formulations for extraintestinal amebiasis. Its established pharmacological properties make it an important ingredient in specialized antimalarial pharmaceutical manufacturing.

Product Name: Chloroquine Phosphate Powder

Chemical Name: Chloroquine Diphosphate

Common Name: Chloroquine Phosphate / Chloroquine Diphosphate / Chloroquine Phosphate API

CAS No.: 50-63-5

Molecular Formula: C18H26ClN3·2H3PO4

Molecular Weight: 515.86 g/mol

Category: Active Pharmaceutical Ingredient (API) / Antimalarial / Antiprotozoal / 4-Aminoquinoline Derivative

Grade: Pharmaceutical Grade / IP / BP / USP (subject to supplier documentation and batch compliance)

Appearance: White to almost white crystalline powder

Source: Synthetically manufactured pharmaceutical compound produced through controlled chemical synthesis, purification, and quality testing.

Solubility: Freely soluble in water; slightly soluble in ethanol. Solubility characteristics may vary with temperature and formulation conditions.

Functions: Antimalarial agent, antiprotozoal agent, heme detoxification inhibitor, and pharmaceutical active ingredient.

Applications:

• Antimalarial pharmaceutical manufacturing

• Chloroquine Phosphate tablet formulations

• Oral antimalarial medicine preparations

• Malaria treatment formulations for susceptible parasites

• Malaria prevention formulations where approved

• Extraintestinal amebiasis treatment formulations

• Antiprotozoal pharmaceutical preparations

• Tropical disease pharmaceutical manufacturing

• Oral solid dosage form manufacturing

• Pharmaceutical formulation development

• Antimalarial drug research

• Specialty pharmaceutical manufacturing

Packaging: Available in suitable pharmaceutical-grade, moisture-resistant packaging such as sealed HDPE containers, fiber drums, or lined multi-layer bags, subject to customer requirements and commercial availability.

Storage: Store in tightly closed containers in a cool, dry, well-ventilated place. Protect from moisture, excessive heat, and direct sunlight. Follow manufacturer-recommended storage conditions.

Supplier: NR LIFE CARE

Product Quality: Batch-specific specifications may include assay, identification, purity, related substances, pH, loss on drying, residual solvents, elemental impurities, particle size distribution, and Certificate of Analysis (COA). All specifications are subject to confirmation against the supplied batch.

Mebeverine Hydrochloride API is a pharmaceutical active ingredient widely used in the manufacturing of gastrointestinal antispasmodic formulations. It belongs to the musculotropic antispasmodic class and acts directly on smooth muscles of the gastrointestinal tract to help relieve intestinal spasms and abdominal discomfort. Mebeverine Hydrochloride is commonly used in pharmaceutical formulations intended for the symptomatic management of Irritable Bowel Syndrome (IBS) and other functional gastrointestinal disorders. Its smooth muscle relaxant properties make it a valuable ingredient in oral antispasmodic tablets, capsules, and modified-release pharmaceutical preparations.

Product Name: Mebeverine Hydrochloride API

Chemical Name: 4-[Ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl 3,4-dimethoxybenzoate Hydrochloride

Common Name: Mebeverine HCl / Mebeverine Hydrochloride

CAS No.: 2753-45-9

Molecular Formula: C25H35NO5·HCl

Molecular Weight: 466.01 g/mol

Category: Active Pharmaceutical Ingredient (API) / Gastrointestinal Antispasmodic / Smooth Muscle Relaxant

Grade: Pharmaceutical Grade / IP / BP / EP / USP (as applicable and supported by supplier documentation)

Appearance: White to almost white crystalline powder

Source: Synthetically manufactured pharmaceutical compound produced through controlled chemical synthesis and purification.

Solubility: Soluble in water and ethanol; solubility depends on temperature and formulation conditions.

Functions: Gastrointestinal antispasmodic, intestinal smooth muscle relaxant, abdominal spasm relief agent, and pharmaceutical active ingredient.

Applications:

• Pharmaceutical antispasmodic tablet manufacturing

• Mebeverine Hydrochloride tablet formulations

• Sustained-release capsule manufacturing

• Modified-release oral dosage formulations

• Irritable Bowel Syndrome (IBS) management formulations

• Gastrointestinal spasm management preparations

• Functional bowel disorder formulations

• Abdominal discomfort management medicines

• Gastrointestinal pharmaceutical products

• Oral solid dosage form manufacturing

• Pharmaceutical formulation development

• Specialty gastrointestinal medicine manufacturing

• Commercial pharmaceutical manufacturing

Packaging: Available in suitable pharmaceutical-grade, moisture-resistant packaging such as sealed HDPE containers, fiber drums, or lined multi-layer packaging as per customer requirements and commercial availability.

Storage: Store in a tightly closed container in a cool, dry, well-ventilated place, protected from moisture, excessive heat, and direct sunlight. Follow the manufacturer's recommended storage conditions to maintain chemical stability and product quality.

Supplier: NR LIFE CARE

Product Quality: Grade-specific specifications, assay, purity, identification, related substances, melting point, water content, loss on drying, residual solvents, elemental impurities, particle size distribution, and Certificate of Analysis (COA) are subject to confirmation against the supplied batch.

Para Aminobenzoic Acid (PABA) is an aromatic organic compound belonging to the aminobenzoic acid family. It is widely used as a chemical intermediate in pharmaceutical synthesis, specialty chemical manufacturing, dyes, and selected industrial applications.

Para Aminobenzoic Acid contains both amino and carboxylic acid functional groups attached to a benzene ring. This chemical structure makes it useful as a building block for the synthesis of various organic compounds.

PABA is involved in bacterial folate biosynthesis and is an important intermediate in the preparation of selected pharmaceutical and chemical compounds. It has also been used historically in sunscreen formulations, although its cosmetic use is restricted in some jurisdictions.

Product Name: Para Aminobenzoic Acid 99%

Chemical Name: 4-Aminobenzoic Acid

Common Name: PABA / Para Aminobenzoic Acid / p-Aminobenzoic Acid

CAS No.: 150-13-0

Molecular Formula: C7H7NO2

Molecular Weight: 137.14 g/mol

Category: Pharmaceutical Intermediate / Specialty Chemical / Organic Chemical

Grade: 99% Purity / Manufacturer-Specified Grade

Appearance: White to off-white crystalline powder.

Source: Synthetically manufactured aromatic organic compound.

Solubility: Slightly soluble in water; soluble in selected organic solvents.

Chemical Classification: Aromatic Amino Carboxylic Acid

Functional Category: Pharmaceutical Intermediate / Chemical Building Block

Purity: 99%, subject to batch-specific COA confirmation.

Applications:

• Pharmaceutical intermediate manufacturing

• Specialty organic chemical synthesis

• Dye and pigment intermediate production

• Chemical research and development

• Analytical laboratory applications

• Industrial chemical manufacturing

• Selected cosmetic ingredient applications, where permitted

Key Features:

• Aromatic organic compound

• Contains amino and carboxylic acid groups

• Useful pharmaceutical synthesis intermediate

• Suitable for specialty chemical applications

• Defined chemical structure

• Batch-specific purity specifications

Packaging: Suitable tightly sealed, moisture-resistant bags or containers, subject to availability.

Storage: Store in a cool, dry, well-ventilated environment, protected from moisture, excessive heat, and direct sunlight.

Supplier & Trader: NR LIFE CARE, Ahmedabad, Gujarat, India

Product Quality: Specifications may include identification, assay, melting range, moisture content, related impurities, and residual solvents.

Documentation: Certificate of Analysis (COA), technical specifications, and Safety Data Sheet (SDS), subject to availability.

Safety: Chemical raw material intended for authorized industrial, pharmaceutical manufacturing, and laboratory applications. Appropriate protective equipment and handling procedures are required.

Regulatory Note: Pharmaceutical and cosmetic applications must comply with applicable product-specific regulations and grade requirements.

Cetirizine Dihydrochloride is a second-generation antihistamine active pharmaceutical ingredient (API) widely used in pharmaceutical manufacturing for approved medicines intended to manage allergic conditions.

Cetirizine acts as a selective peripheral histamine H1 receptor antagonist, reducing histamine-mediated allergic symptoms such as sneezing, itching, watery eyes, and rhinorrhea.

It is commonly used in approved oral pharmaceutical formulations, including tablets, capsules, syrups, and oral solutions.

Product Name: Cetirizine Dihydrochloride Powder

Chemical Name: 2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride

Common Name: Cetirizine HCl / Cetirizine Dihydrochloride / Cetirizine API

CAS No.: 83881-52-1

Molecular Formula: C21H25ClN2O3·2HCl

Molecular Weight: 461.81 g/mol

Category: Active Pharmaceutical Ingredient / Antihistamine API / Anti-Allergic API

Grade: IP / BP / USP / Pharmaceutical Grade, subject to batch-specific compliance.

Appearance: White to almost white crystalline powder.

Source: Synthetically manufactured pharmaceutical compound.

Solubility: Freely soluble in water; confirm against batch-specific specifications.

Chemical Classification: Piperazine Derivative / Second-Generation Antihistamine

Therapeutic Category: Antihistamine / Anti-Allergic Agent

Mechanism of Action: Selectively blocks peripheral histamine H1 receptors, reducing allergic responses.

Applications:

• Cetirizine tablet manufacturing

• Oral syrup and solution formulations

• Antihistamine capsule manufacturing

• Allergic rhinitis medicines

• Approved urticaria treatments

• Generic pharmaceutical manufacturing

• Pharmaceutical formulation development

• Analytical testing and quality control

Key Features:

• Second-generation antihistamine API

• Selective peripheral H1 receptor antagonist

• Established anti-allergic pharmaceutical ingredient

• Suitable for approved oral formulations

• Defined chemical composition

• Batch-specific quality specifications

Packaging: Pharmaceutical-grade, tightly sealed, moisture-resistant containers or lined drums, subject to availability.

Storage: Store in tightly closed containers under manufacturer-recommended conditions. Protect from moisture, excessive heat, and direct sunlight.

Supplier: NR LIFE CARE

Product Quality: Batch-specific specifications may include identification, assay, related substances, residual solvents, water content, and particle size.

Documentation: Certificate of Analysis (COA), technical specifications, and Safety Data Sheet (SDS) may be available upon request.

Regulatory Note: Intended exclusively for authorized pharmaceutical manufacturing in accordance with applicable regulations.

Fenbendazole API Powder is a broad-spectrum veterinary anthelmintic active pharmaceutical ingredient belonging to the benzimidazole class. It is widely used in veterinary pharmaceutical manufacturing for the development of deworming formulations intended to control susceptible gastrointestinal parasites in animals.

Fenbendazole works by binding to parasite beta-tubulin and inhibiting microtubule formation. This disrupts essential cellular functions, including nutrient uptake and energy metabolism, ultimately leading to parasite elimination.

Fenbendazole is commonly used in veterinary formulations for livestock, companion animals, and other approved animal species. It is an important raw material for the manufacturing of veterinary antiparasitic medicines.

Product Name: Fenbendazole API Powder

Chemical Name: Methyl 5-(phenylthio)-1H-benzimidazol-2-ylcarbamate

Common Name: Fenbendazole / Fenbendazole API / Fenbendazole Powder

CAS No.: 43210-67-9

Molecular Formula: C15H13N3O2S

Molecular Weight: 299.35 g/mol

Category: Veterinary Active Pharmaceutical Ingredient / Benzimidazole Anthelmintic / Antiparasitic Agent / Veterinary Pharmaceutical Raw Material

Grade: Veterinary Pharmaceutical Grade / Pharmacopoeial Grade, subject to supplier documentation and batch-specific compliance.

Appearance: White to off-white crystalline powder.

Source: Synthetically manufactured benzimidazole compound produced through controlled chemical synthesis, purification, crystallization, and quality testing.

Solubility: Practically insoluble in water; solubility varies in selected organic solvents depending on formulation conditions.

Functions: Anthelmintic agent, antiparasitic ingredient, microtubule formation inhibitor, and veterinary pharmaceutical active ingredient.

Applications:

• Veterinary deworming medicine manufacturing

• Fenbendazole oral suspension production

• Veterinary tablet manufacturing

• Veterinary granule formulations

• Veterinary paste formulations

• Livestock antiparasitic medicines

• Cattle deworming formulations

• Sheep and goat deworming preparations

• Equine deworming formulations

• Canine veterinary medicines

• Selected feline veterinary formulations

• Veterinary pharmaceutical research

• Anthelmintic formulation development

• Commercial veterinary medicine manufacturing

Packaging: Available in suitable pharmaceutical-grade, moisture-resistant packaging, including sealed HDPE containers, lined fibre drums, or multi-layer bags, subject to customer requirements and commercial availability.

Storage: Store in tightly closed containers under manufacturer-recommended conditions. Protect from moisture, excessive heat, direct sunlight, and contamination.

Supplier: NR LIFE CARE

Product Quality: Batch-specific specifications may include identification, assay, related substances, loss on drying, residual solvents, elemental impurities, particle size distribution, and applicable veterinary pharmaceutical quality parameters. All specifications are subject to confirmation against the supplied batch.

Documentation: Certificate of Analysis (COA), technical specifications, and Safety Data Sheet (SDS) may be provided subject to supplier availability.

Miconazole Nitrate is a synthetic broad-spectrum antifungal active pharmaceutical ingredient (API) belonging to the imidazole class of antifungal agents. It is widely used in pharmaceutical manufacturing for the development of topical, vaginal, and other approved antifungal formulations.

Miconazole Nitrate works primarily by inhibiting fungal lanosterol 14-alpha-demethylase, an enzyme involved in ergosterol biosynthesis. This disrupts fungal cell membrane structure and function, helping control susceptible fungal infections.

It exhibits antifungal activity against various dermatophytes and yeasts, including susceptible Candida species. Its established pharmaceutical applications make it an important raw material for dermatological and antifungal medicine manufacturing.

Product Name: Miconazole Nitrate IP BP USP

Chemical Name: Miconazole Nitrate

Common Name: Miconazole Nitrate / Miconazole Nitrate API / Miconazole Nitrate Powder

CAS No.: 22832-87-7

Molecular Formula: C18H14Cl4N2O·HNO3

Molecular Weight: 479.14 g/mol

Category: Active Pharmaceutical Ingredient (API) / Imidazole Antifungal / Dermatological Pharmaceutical Ingredient

Grade: IP / BP / USP / Pharmaceutical Grade, subject to supplier documentation and batch-specific compliance.

Appearance: White or almost white crystalline powder.

Source: Synthetically manufactured imidazole antifungal compound produced through controlled chemical synthesis, nitrate salt formation, purification, and quality testing.

Solubility: Practically insoluble in water; soluble in selected organic solvents. Solubility depends on solvent composition, temperature, and formulation conditions.

Functions: Antifungal agent, ergosterol synthesis inhibitor, dermatological active ingredient, and pharmaceutical raw material.

Applications:

• Antifungal cream manufacturing

• Miconazole Nitrate ointment production

• Topical antifungal gel formulations

• Dermatological pharmaceutical manufacturing

• Vaginal antifungal preparations

• Antifungal powder manufacturing

• Athlete's foot treatment formulations

• Ringworm treatment preparations

• Cutaneous candidiasis formulations

• Antifungal lotion manufacturing

• Specialty dermatological medicine production

• Pharmaceutical formulation development

• Commercial pharmaceutical manufacturing

Packaging: Available in suitable pharmaceutical-grade, moisture-resistant and light-protective packaging, including sealed HDPE containers, fibre drums, or lined multi-layer bags, subject to customer requirements and commercial availability.

Storage: Store in tightly closed containers under manufacturer-recommended conditions. Protect from moisture, excessive heat, direct sunlight, and contamination.

Supplier: NR LIFE CARE

Product Quality: Batch-specific specifications may include identification, assay, related substances, purity, melting range, loss on drying, residual solvents, elemental impurities, and particle size distribution. All specifications are subject to confirmation against the supplied batch.

Documentation: Certificate of Analysis (COA), technical specifications, and Safety Data Sheet (SDS) may be provided subject to supplier availability.